ITRM910002A1 - Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. - Google Patents

Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.

Info

Publication number
ITRM910002A1
ITRM910002A1 IT000002A ITRM910002A ITRM910002A1 IT RM910002 A1 ITRM910002 A1 IT RM910002A1 IT 000002 A IT000002 A IT 000002A IT RM910002 A ITRM910002 A IT RM910002A IT RM910002 A1 ITRM910002 A1 IT RM910002A1
Authority
IT
Italy
Prior art keywords
treatment
carnitine
acetyl
coma
pharmaceutical compositions
Prior art date
Application number
IT000002A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM910002A0 publication Critical patent/ITRM910002A0/it
Priority to ITRM910002A priority Critical patent/IT1244636B/it
Priority to ZA9110037A priority patent/ZA9110037B/xx
Priority to JP34691591A priority patent/JP3145451B2/ja
Priority to IE456891A priority patent/IE66025B1/en
Priority to DE69201660T priority patent/DE69201660T2/de
Priority to ES91830583T priority patent/ES2070478T3/es
Priority to DK91830583.0T priority patent/DK0498144T3/da
Priority to AT91830583T priority patent/ATE119770T1/de
Priority to EP91830583A priority patent/EP0498144B1/en
Priority to US07/816,224 priority patent/US5192805A/en
Publication of ITRM910002A1 publication Critical patent/ITRM910002A1/it
Application granted granted Critical
Publication of IT1244636B publication Critical patent/IT1244636B/it
Priority to GR940403979T priority patent/GR3015431T3/el
Priority to HK98104930A priority patent/HK1005847A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ITRM910002A 1991-01-04 1991-01-04 Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. IT1244636B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM910002A IT1244636B (it) 1991-01-04 1991-01-04 Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
ZA9110037A ZA9110037B (en) 1991-01-04 1991-12-20 The use of acetyl l-carnitine in the therapeutic treatment of coma and pharmacological compositions useful in such treatment
JP34691591A JP3145451B2 (ja) 1991-01-04 1991-12-27 昏睡治療のためのアセチル−ｌ−カルニチンおよび医薬組成物
IE456891A IE66025B1 (en) 1991-01-04 1991-12-30 Use of acetyl L-carnitine in the therapeutic treatment of coma
DK91830583.0T DK0498144T3 (da) 1991-01-04 1992-01-01 Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
ES91830583T ES2070478T3 (es) 1991-01-04 1992-01-01 El empleo de acetil l-carnitina en el tratamiento terapeutico de coma.
DE69201660T DE69201660T2 (de) 1991-01-04 1992-01-01 Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
AT91830583T ATE119770T1 (de) 1991-01-04 1992-01-01 Verwendung von acetyl l-carnitin zur therapeutischen behandlung von coma.
EP91830583A EP0498144B1 (en) 1991-01-04 1992-01-01 Use of acetyl L-carnitine in the therapeutic treatment of coma
US07/816,224 US5192805A (en) 1991-01-04 1992-01-03 Use of acetyl l-carnitine in the therapeutic treatment of coma
GR940403979T GR3015431T3 (en) 1991-01-04 1995-03-16 Use of acetyl L-carnitine in the therapeutic treatment of coma.
HK98104930A HK1005847A1 (en) 1991-01-04 1998-06-05 Use of acetyl l-carnitine in the therapeutic treatment of coma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910002A IT1244636B (it) 1991-01-04 1991-01-04 Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.

Publications (3)

Publication Number Publication Date
ITRM910002A0 ITRM910002A0 (it) 1991-01-04
ITRM910002A1 true ITRM910002A1 (it) 1992-07-04
IT1244636B IT1244636B (it) 1994-08-08

Family

ID=11399703

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910002A IT1244636B (it) 1991-01-04 1991-01-04 Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.

Country Status (12)

Country Link
US (1) US5192805A (it)
EP (1) EP0498144B1 (it)
JP (1) JP3145451B2 (it)
AT (1) ATE119770T1 (it)
DE (1) DE69201660T2 (it)
DK (1) DK0498144T3 (it)
ES (1) ES2070478T3 (it)
GR (1) GR3015431T3 (it)
HK (1) HK1005847A1 (it)
IE (1) IE66025B1 (it)
IT (1) IT1244636B (it)
ZA (1) ZA9110037B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US5872008A (en) * 1996-02-09 1999-02-16 Bair; Glenn O. Methods for diagnosing pre-menstrual syndrome
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
ES2210705T5 (es) 1998-03-19 2011-02-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composición combinada que comprende una l-carnitina o una alcanoil-l-carnitina, un glucosaminoglucano y/o un constituyente del mismo.
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
MX2012014127A (es) * 2010-06-16 2013-06-28 Sigma Tau Ind Farmaceuti Acetil-carnitina para uso en un metodo para incrementar neurogenesis en tejido nervioso.
EP2586438A1 (en) 2011-10-28 2013-05-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
IT1184655B (it) * 1985-10-14 1987-10-28 Sigma Tau Ind Farmaceuti Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.

Also Published As

Publication number Publication date
GR3015431T3 (en) 1995-06-30
IE66025B1 (en) 1996-01-10
EP0498144B1 (en) 1995-03-15
ZA9110037B (en) 1992-09-30
ATE119770T1 (de) 1995-04-15
HK1005847A1 (en) 1999-01-29
DE69201660T2 (de) 1995-07-20
EP0498144A1 (en) 1992-08-12
ITRM910002A0 (it) 1991-01-04
JPH04295424A (ja) 1992-10-20
US5192805A (en) 1993-03-09
DE69201660D1 (de) 1995-04-20
JP3145451B2 (ja) 2001-03-12
IT1244636B (it) 1994-08-08
DK0498144T3 (da) 1995-07-24
ES2070478T3 (es) 1995-06-01
IE914568A1 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
IT1196564B (it) Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
DE69123795D1 (de) Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau
IT1235153B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
ATE173627T1 (de) Medizinische zusammensetzung
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
ATE132494T1 (de) Substituierte 3-piperazinylalkyl 2,3-dihydro-4h- 1,3-benzoxazin-4-one, deren herstellung und verwendung in heilkunde
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
KR910018038A (ko) 원발성 흉막암의 치료를 위한 제약 조성물 제조용 인체 인터루킨 2활성 함유 폴리펩티드의 용도
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
KR890004705A (ko) 항바이러스성 제제
ITRM950544A0 (it) Uso della l-carnitina di suoi derivati e di loro sali farmaceuticamen-te accettabili in combinazione con farmaci antiretrovirali per ridurrei livelli di ceramide e potenziare l'attivita' di tali farmaci antire-trovirali per il trattamento terapeutico dell'invenzione...
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
IT1224250B (it) Associzione del depiprazolo con la morfina
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
GB9202993D0 (en) Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
KR920014480A (ko) 기흉 치료용 제약 조성물을 제조하기 위한 인간 인터류킨 2의 활성을 갖는 폴리펩티드의 용도
ES2127133B1 (es) Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931202